Praxis Precision Medicines (PRAX) director receives RSU and option grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Praxis Precision Medicines director Stuart A. Arbuckle reported equity compensation awards. He received 1,371 restricted stock units, each representing a contingent right to one share of common stock, vesting in a single installment on the earlier of June 10, 2027 or the company’s 2027 annual stockholder meeting. He was also granted options to purchase 648 shares of common stock at an exercise price of $240.66 per share, vesting in twelve equal monthly installments beginning July 10, 2026 and ending on the earlier of June 10, 2027 or the 2027 annual meeting. After these awards, he directly holds 2,537 common shares and 648 stock options, reflecting routine director compensation rather than open-market buying.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Arbuckle Stuart A
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 648 | $0.00 | -- |
| Grant/Award | Common Stock | 1,371 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 648 shares (Direct, null);
Common Stock — 2,537 shares (Direct, null)
Footnotes (1)
- Mr. Arbuckle was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
Key Figures
RSU grant: 1,371 units
Shares after award: 2,537 shares
Option grant size: 648 options
+4 more
7 metrics
RSU grant
1,371 units
Restricted stock units awarded to director on June 10, 2026
Shares after award
2,537 shares
Common stock directly held after RSU grant
Option grant size
648 options
Stock options granted on June 10, 2026
Option exercise price
$240.66 per share
Conversion or exercise price for 648 options
Option expiration
June 10, 2036
Expiration date of stock option grant
RSU vesting date
June 10, 2027 or 2027 meeting
Single-installment vesting trigger for 1,371 RSUs
Option vesting start
July 10, 2026
First of twelve monthly vesting installments for options
Key Terms
restricted stock units, contingent right, stock option, vest, +1 more
5 terms
restricted stock units financial
"Mr. Arbuckle was awarded 1,371 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share."
stock option financial
"The shares subject to this option shall vest in twelve (12) equal monthly installments."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price": "240.6600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider transactions did Praxis Precision Medicines (PRAX) report for Stuart Arbuckle?
Praxis Precision Medicines reported that director Stuart A. Arbuckle received 1,371 restricted stock units and stock options for 648 shares as equity compensation, rather than making any open-market share purchases or sales.
What are the vesting terms of Stuart Arbuckle’s 1,371 Praxis restricted stock units?
The 1,371 restricted stock units vest in a single annual installment on the earlier of June 10, 2027 or the date of Praxis Precision Medicines’ 2027 annual meeting of stockholders, and are settled only in shares of common stock.
What are the key terms of Stuart Arbuckle’s Praxis stock option grant?
Stuart Arbuckle received options for 648 shares of Praxis common stock at a $240.66 exercise price, vesting in twelve equal monthly installments from July 10, 2026 through the earlier of June 10, 2027 or the 2027 annual meeting, expiring June 10, 2036.
Does this Praxis (PRAX) Form 4 show insider buying or selling in the market?
The Form 4 shows equity compensation grants, not market trades. Stuart Arbuckle acquired restricted stock units and stock options at no cash cost, with no open-market share purchases or sales reported in this filing.